David Bliklen
Neurology · Glendale, AZNPI 1548223936
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations.
Across 135 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$366
- Novartis$239
- Biogen$194
- Teva Pharmaceuticals USA, Inc.$159
- Sanofi$137
- Livanova USA, Inc.$127
- plus $845 from 20 others
What the payments were for
- Speaking & faculty fees$412%
- Food & beverage$2,02698%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 21 | $366 |
| Novartis | 14 | $239 |
| Biogen | 10 | $194 |
| Teva Pharmaceuticals USA, Inc. | 24 | $159 |
| Sanofi | 11 | $137 |
| Livanova USA, Inc. | 4 | $127 |
| Genentech USA, Inc. | 5 | $85 |
| Sunovion Pharmaceuticals Inc. | 3 | $84 |
| EMD Serono, Inc. | 5 | $81 |
| Acadia Pharmaceuticals Inc | 4 | $69 |
| Amneal Pharmaceuticals LLC | 4 | $55 |
| Supernus Pharmaceuticals, Inc. | 4 | $54 |
| Acorda Therapeutics, Inc | 4 | $53 |
| AbbVie | 3 | $44 |
| Zyla Life Sciences, Inc. | 3 | $44 |
| Lilly USA, LLC | 3 | $40 |
| Medtronic | 2 | $36 |
| Mallinckrodt Enterprises LLC | 1 | $35 |
| Amgen | 2 | $33 |
| AstraZeneca | 2 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Shire North American Group Inc | 1 | $22 |
| Pfizer | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| MDD US Operations, LLC | 1 | $13 |
How this compares
$2,067 in reported general payments places this provider in the 55th percentile of 388 neurology providers in Arizona.
Other neurology in Glendale
- Darry JohnsonGlendale$297K
- Barry HendinPhoenix$2.3M
- Maria OspinaPhoenix$2.1M
- Suraj MuleyPhoenix$1.7M
- Nida LaurinScottsdale$969K
- Eric ErossPhoenix$778K
- Steve ChungPhoenix$685K
- Marwan SabbaghPhoenix$603K
- Kerry KnievelPhoenix$509K
- Jonathan HodgsonGilbert$408K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.